Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population

  1. Castellano, D.
  2. Garcia del Muro, X.
  3. Pérez-Gracia, J.L.
  4. González-Larriba, J.L.
  5. Abrio, M.V.
  6. Ruiz, M.A.
  7. Pardo, A.
  8. Guzmán, C.
  9. Díaz Cerezo, S.
  10. Grande, E.
Aldizkaria:
Annals of Oncology

ISSN: 0923-7534,  1569-8041

Argitalpen urtea: 2009

Alea: 20

Zenbakia: 11

Orrialdeak: 1803-1812

Mota: Artikulua

DOI: 10.1093/ANNONC/MDP067 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus